STOCK TITAN

Medtronic plc - $MDT STOCK NEWS

Welcome to our dedicated page for Medtronic plc news (Ticker: $MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic plc stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medtronic plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medtronic plc's position in the market.

Rhea-AI Summary

Medtronic's latest technology, the MiniMedTM 780G system with Meal DetectionTM technology, is helping individuals like Jodie Snavely manage their type 1 diabetes effectively. The system automatically adjusts and corrects sugar levels every five minutes, preventing blood sugar spikes. This advancement in diabetes management technology provides peace of mind to users by maintaining stable blood sugar levels, reducing the need for constant monitoring and worry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Medtronic plc (NYSE:MDT) will announce its financial results for the fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. The company will release summary financial information for the period ending on Friday, April 26, 2024. The results will be discussed in a video webcast at 7:00 a.m. CDT on the same day, with a replay and transcript available within 24 hours. Medtronic plans to report fiscal year 2025 results on various dates later in the year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

In a recent press release by Medtronic, Chief Scientific and Medical Officer Laura Mauri discusses the intersection of healthcare and technology in achieving longevity. While many Americans aspire to live past 90, the survey reveals a preference for a shorter, healthier life. Despite belief in healthcare technology, engagement in preventative measures remains low. Medtronic aims to bridge this gap by providing innovative solutions that enhance patient outcomes and experiences. By sharing four actions under the acronym T.E.C.H., individuals are encouraged to take charge of their health and well-being.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
none
Rhea-AI Summary

Medtronic's groundbreaking SMART clinical trial focusing on women with aortic stenosis marks a pivotal moment in women's health. The study compared Medtronic's Evolut transcatheter aortic heart valve system with Edwards Sapien, revealing superior performance of the Evolut system. Female-specific data from the trial sheds light on gender inequities in heart health care, emphasizing the need to address underrepresentation of women in clinical trials.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
-
Rhea-AI Summary
Medtronic plc (NYSE:MDT) has received FDA approval for its Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for treating chronic pain. This innovative device is the first of its kind to offer closed-loop sensing capability, adjusting therapy in real time to match the patient's needs. Dr. Krishnan Chakravarthy, a leading expert in pain treatment, highlights the significance of this advancement in personalized pain management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
-
Rhea-AI Summary
A survey from Medtronic and Morning Consult reveals that most U.S. adults prioritize quality of life over longevity, with nearly two-thirds preferring a shorter, healthier life. The survey highlights the importance of health and well-being for Americans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
Rhea-AI Summary
A new survey from Medtronic and Morning Consult reveals that nearly two-thirds of U.S. adults prioritize a shorter, healthier life over a longer one with health issues. This shift towards quality over quantity in pursuit of longevity reflects changing attitudes towards health and well-being.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
none
-
Rhea-AI Summary
Medtronic plc announced the launch of ColonPRO™ software for the GI Genius™ intelligent endoscopy system, enhancing AI-driven polyp detection with a 9% reduction in false positives. The collaboration with Modernizing Medicine® aims to streamline workflows and improve patient care in endoscopic procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
AI
-
Rhea-AI Summary
Medtronic LABS aims to expand access to essential healthcare in Kenya, showcasing their mission through a documentary 'A Voice for Health'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
Rhea-AI Summary
Medtronic plc (MDT) announces positive clinical trial results for Sphere-360 catheter, showing high efficacy and safety in treating atrial fibrillation. The catheter, fully integrated with Affera™ Mapping and Ablation System, demonstrated 81.8% freedom from atrial arrhythmias after one year of follow-up. The study also highlighted 100% freedom in the sub-group treated with the optimized pulse configuration, with a treatment time of 10 minutes on average. The Sphere-360 catheter showed 96% sustained lesion durability in patients treated with the optimized pulse. The innovative design of the catheter allows for efficient energy delivery, tissue-conformable lattice tip, and compatibility with various PV anatomies. The study emphasized the catheter's safety profile with zero primary safety adverse events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
Medtronic plc

NYSE:MDT

MDT Rankings

MDT Stock Data

109.89B
1.33B
0.11%
85.18%
0.94%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
DUBLIN

About MDT

Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.